Close Menu
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing & Mental Health
  • Marketing
  • HR & Recruitment
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
X (Twitter) LinkedIn YouTube
Trending
  • From Uncertainty to Opportunity: Why Buying Commercial Property Makes Sense Right Now
  • What every UK company director needs to know in 2025
  • Putting information security first is your first step to building digital trust.
  • Industry Leaders Choose NC Group for Pearson-Approved HNC in Engineering
  • Why audit trails matter more than ever
  • Allergen Free For The Win: Ceo Of Inclusive Food Brand Announced As Best Business Woman
  • Growing talent from within: why apprenticeships work where traditional hiring falls short
  • Study Shows Majority Of Gen Z Have Side Hustles – Generational Expert Offers Advice To Employers
X (Twitter) LinkedIn YouTube
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing
  • Marketing
  • HR & Recruitment
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
You are at:Home»News»Daemon reduces Tachmed’s scientists’ clinical investigation time by 50% with AI
Daemon reduces Tachmed’s scientists' clinical investigation time by 50% with AI, accelerating breakthroughs in healthcare diagnostics

Daemon reduces Tachmed’s scientists’ clinical investigation time by 50% with AI

0
Posted By Greg Robinson on March 13, 2025 News, Technology

Digital transformation consultancy Daemon announces new collaboration with UK-based healthcare company Tachmed  to enhance the speed and efficiency of bringing innovative healthcare products to the market faster. By leveraging AI to identify clinical uses and antibodies for testing, the collaboration enables Tachmed to streamline its workflows, saving as much as 50% of time that would’ve previously been spent conducting this in-depth research without support.

To accelerate clinical and use-case identification and reduce delays in developing Tachmed’s extensive assay library, Tachmed collaborated with Daemon to identify the most impactful opportunities for AI integration. Through stakeholder engagement, two-way education, upskilling initiatives and hands-on workshops, Daemon worked closely with scientists to understand key challenges in clinical use-case identification. This foundational work helped shape AI adoption, minimising delays in developing Tachmed’s extensive assay (test) library and ensuring scientists could focus on high-value research.

Innovation with AI, the Daemon way

Tachmed’s success relies on rapid discovery and evaluation of potential clinical use cases and diagnostic reagents, such as antibodies, for assay development. Previously, scientists manually sifted through scientific literature and vendor data, a process that was time-consuming, costly and prone to bottlenecks.

Daemon identified a three-step approach to using AI to eliminate these hurdles:

  1. Using AI to extract the right information: Using Anthropic’s Claude’s Sonnet 3.5, available through Amazon Bedrock, the AI model extracts insights from PubMed and vendor websites. The AI also extracts antibody data.
  2. Organising information for ease of use: Once the AI has extracted the key data, again powered by Anthropic’s Claude on AWS Bedrock, it organises it with two steps. First, it identifies key details, biomarkers, test types, and clinical significance. Then it synthesises the extracted data to deliver targeted, actionable, and organised insights, enabling scientists to make informed decisions without sifting through vast amounts of research or spreadsheets. This approach helps researchers efficiently identify biomarkers and clinical opportunities, accelerating assay development, saving time, and supporting faster, data-driven decision-making.
  3. A scalable system for the future: Built on AWS’s managed services, the system is designed to scale with Tachmed’s growing needs, ensuring smooth performance and efficient data processing, even as the volume of information increases. AWS’ scalable infrastructure supports long-term growth while maintaining seamless operation.

To ensure rapid and effective adoption of AI solutions, Daemon also educated scientists, developers, and non-technical stakeholders on AI’s capabilities, helping to build a long-term, scalable vision. Additionally, Daemon designed and implemented a tailored user interface with an iterative approach, incorporating user feedback and testing.

Damien Duff, Principal Consultant, Machine Learning at Daemon comments, “We are committed to helping organisations harness AI to drive meaningful change. This project exemplifies how AI can improve efficiency and unlock new opportunities for innovation. By automating critical processes and enabling faster decision-making, we’re empowering scientists to focus on the breakthroughs that matter.

“Our work with Tachmed demonstrates that AI and innovation create significant opportunities to accelerate the development of healthcare products.”

Delivering measurable impact

The collaboration between Daemon and Tachmed hasrated significant real-world impact, empowering innovation as Tachmed’s team now has access to AI-driven tools to quickly discover clinical use cases and antibody candidates, driving their mission to create transformative healthcare solutions. It has also accelerated development, with the tool saving scientists up to a week on every two-week literature review and up to a week per clinical project, thereby speeding up research and reducing time-to-market for new healthcare products. Additionally, what started as a proof of concept is now in active use and ready to scale,architecture set to automate data scraping and handle larger datasets; future developments will extend AI capabilities to support data analysis and testing processes. already demonst with AI-driven

Paul Christie, CEO, Tachmed comments, “Daemon’s expertise and collaboration has been instrumental in helping us build tools that align with our mission to transform healthcare data and diagnostics. The AI-powered system the team developed is already saving us time, delivering valuable insights, and enabling us to innovate faster.

“It is the first step of using AI to revolutionise assay development and moving downstream to frontline remote, predictive, and automated user applications. This partnership is a game-changer.”

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

What every UK company director needs to know in 2025

Putting information security first is your first step to building digital trust.

Industry Leaders Choose NC Group for Pearson-Approved HNC in Engineering

Comments are closed.

Follow SME Today on Linkedin and share all the topics you find interesting
ISO/IEC 27001 roadmap: A practical guide for UK SMEs
ISO/IEC 27001 roadmap: A practical guide for UK SMEs
Are you a Company Director?
Are you a Company Director - Verify your identity
Personal Pension offer
Events Calendar
    • Marketing
    September 19, 2025

    Email Out, LinkedIn In. Shift In B2B Lead Generation Strategies

    September 9, 2025

    SEO 101 for SMBs: Reaching Customers with the Right Visuals

    • Finance
    October 1, 2025

    Why audit trails matter more than ever

    September 24, 2025

    IW Capital Invests £4m into Navigator to Power the Future of Privacy-First Advertising In A Post-Cookie World

    • People
    September 30, 2025

    Allergen Free For The Win: Ceo Of Inclusive Food Brand Announced As Best Business Woman

    September 18, 2025

    ClearCourse appoints new Chair of the Board, Simon Black

    • Health & Safety
    September 18, 2025

    Lessons From Grenfell Are Still Being Learned

    September 2, 2025

    1 in 3 employees anxious about lack of first aiders at work

    • Events
    September 9, 2025

    Nominations for the 2026 Bold Woman Award by Veuve Clicquot open

    July 22, 2025

    South West Expo Delivers Outstanding Event at Swindon’s STEAM Museum

    • Community
    September 18, 2025

    ClearCourse appoints new Chair of the Board, Simon Black

    September 18, 2025

    Raising Money Where It’s Needed: Westspring Pledges To Raise £50,000 For Charity

    • Food & Drink
    September 25, 2025

    Unconform Cold Brew Coffee Lauds Holland & Barrett’s Wise Counsel

    August 22, 2025

    How to get stocked by major retailers as an SME

    • Books
    September 3, 2025

    New book on conquering fear of public speaking

    August 7, 2025

    Learning to Leave a Legacy in Business

    The Newsletter

    Join our mailing list for the best SME stories, handpicked and delivered direct to your inbox every two weeks!

    Sign Up
    About

    SME Today is published by the same team who deliver The Great British Expos’. We have been organising various corporate events for the last 10 years, with a strong track record of producing well managed and attended business events across the UK.

    Join Our Mailing List

    Receive the latest news and updates from SMEToday.
    Read our Latest Newsletter:


    Sign Up
    X (Twitter) YouTube LinkedIn
    Categories
    • Books
    • Community & Charity
    • Education and Training
    • Environment
    • Events
    • Features
    • Finance
    • Food and Drink
    • Health & Safety
    • HR & Recruitment
    • In Profile
    • Legal
    • Marketing
    • News
    • People
    • Property & Development
    • Sponsored Content
    • Technology
    • Transport & Tourism
    • Wellbeing & Mental Health
    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Editorial Submission Guidelines
    • Privacy
    • Contact
    Copyright © 2025 SME Today.
    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Editorial Submission Guidelines
    • Privacy
    • Contact

    Type above and press Enter to search. Press Esc to cancel.